Device companies seeking global market access can no longer ignore health technology assessment bodies, but there are an expanding number of HTA pathways that firms can utilize, particularly for truly innovative, next-generation technology, experts said during a recent panel discussion at MedTech Strategist’s Virtual Innovation Summit Dublin 2021. Check out the full video.
Read the full article: https://bit.ly/3BGuEFE
View the latest issue of Market Pathways: https://bit.ly/3eZUBGw
About Market Pathways
Your premium guide to global medical device regulation, reimbursement and policy. Market Pathways delivers incomparable intelligence exploring the people, challenges, and opportunities impacting the global medtech regulatory and reimbursement community. View the latest issue of Market Pathways on MyStrategist.com
